| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 102.09 mm | 102.09 mm | 102.09 mm | 102.09 mm | 102.09 mm | 102.09 mm |
| Cash burn (monthly) | 4.31 mm | (no burn) | 16.29 mm | 15.61 mm | 11.38 mm | 10.57 mm |
| Cash used (since last report) | 17.34 mm | n/a | 65.50 mm | 62.80 mm | 45.77 mm | 42.50 mm |
| Cash remaining | 84.74 mm | n/a | 36.58 mm | 39.29 mm | 56.31 mm | 59.58 mm |
| Runway (months of cash) | 19.7 | n/a | 2.2 | 2.5 | 4.9 | 5.6 |
| 13F holders | Current |
|---|---|
| Total holders | 141 |
| Opened positions | 19 |
| Closed positions | 18 |
| Increased positions | 67 |
| Reduced positions | 28 |
| 13F shares | Current |
|---|---|
| Total value | 1.08 tn |
| Total shares | 84.14 mm |
| Total puts | 118.00 k |
| Total calls | 611.80 k |
| Total put/call ratio | 0.2 |
| Largest owners | Shares | Value |
|---|---|---|
| UBS Oncology Impact Fund | 7.91 mm | $234.17 mm |
| MPM Oncology Impact Management | 7.65 mm | $128.03 bn |
| Biotechnology Value Fund L P | 5.80 mm | $94.02 mm |
| BVF | 5.75 mm | $96.27 bn |
| BlackRock | 4.34 mm | $72.63 bn |
| Flynn James E | 3.28 mm | $59.31 mm |
| Deerfield Management | 3.28 mm | $54.91 bn |
| Vanguard | 3.00 mm | $50.20 bn |
| STT State Street | 2.34 mm | $39.13 bn |
| Paradigm Biocapital Advisors | 2.32 mm | $38.85 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Jan 25 | Jennifer Michaelson | Common Stock | Sell | Dispose S | No | Yes | 12.51 | 4,000 | 50.04 k | 95,760 |
| 24 Dec 24 | Nadim Ahmed | Common Stock | Sell | Dispose S | No | No | 11.87 | 8,400 | 99.71 k | 263,150 |
| 18 Dec 24 | Jennifer Michaelson | Common Stock | Sell | Dispose S | No | No | 11.41 | 4,693 | 53.55 k | 99,760 |
| 18 Dec 24 | Jacquelyn L Sumer | Common Stock | Sell | Dispose S | No | No | 11.41 | 3,482 | 39.73 k | 90,651 |
| 18 Dec 24 | Jeffrey Alan Jones | Common Stock | Sell | Dispose S | No | No | 11.41 | 4,632 | 52.85 k | 114,059 |
